Core Viewpoint - The Shenzhen Intermediate People's Court has ruled in favor of some investors in a lawsuit against Renzi Hang Network Technology Co., Ltd. (ST Renzi Hang, stock code: 300311) for securities false statement liability [1][3] Summary by Sections Legal Proceedings - Investors are currently being represented in batches for lawsuits against Renzi Hang, with the possibility of compensation for those who purchased shares between April 27, 2021, and August 9, 2024, and still hold them as of the latter date [3][6] - The statute of limitations for claims against Renzi Hang has not yet expired, allowing affected investors to seek legal recourse [1][3] Financial Misconduct - Renzi Hang was found to have inflated its operating income by amounts of 36,951,333.48 yuan, 48,435,351.70 yuan, and 26,929,607.08 yuan from 2020 to the first half of 2022, representing 4.21%, 6.97%, and 10.81% of the reported figures respectively [2][5] - The company also inflated its total profit by 19,406,901.32 yuan, 37,317,431.71 yuan, and 16,560,909.58 yuan during the same period, accounting for 85.93%, 70.03%, and 30.79% of the absolute values of the reported figures [2][5] - The annual reports for 2020, 2021, and the semi-annual report for 2022 contained false records, and the company referenced these inflated figures in its fundraising documents in February 2023 [2][5] Compensation Claims - Investors seeking compensation must provide original documents such as securities account information, stock reconciliation statements from April 1, 2021, to the present, and detailed contact information [3][6] - The scope of compensation includes investment differences, commissions, and stamp duty losses as per the new judicial interpretation by the Supreme Court regarding false statements [2][5]

Core Viewpoint - The case against Shandong Meichen Technology Co., Ltd. involves allegations of false statements in securities, leading to significant financial losses for investors [2][5]. Group 1: Allegations and Financial Impact - From 2014 to 2018, Meichen Technology's subsidiary, Hangzhou Saishi Garden Group Co., Ltd., inflated construction costs and completion percentages through false procurement, resulting in inflated revenues and profits [2][4]. - The company reported inflated revenues of 23.66 million, 372.64 million, 725.61 million, 215.19 million, and 100.68 million yuan for the years 2014 to 2018, representing 2.06%, 20.67%, 24.60%, 5.53%, and 2.88% of the disclosed operating income respectively [2][4]. - The inflated total profits for the same years were 22.93 million, 188.54 million, 259.58 million, 117.43 million, and 69.49 million yuan, accounting for 17.91%, 75.64%, 49.78%, 15.49%, and 15.58% of the disclosed total profits respectively [2][4]. Group 2: Legal Proceedings and Compensation - The case has been accepted by the Qingdao Intermediate People's Court, and affected investors can file claims for compensation [1][3]. - Investors who purchased ST Meichen stock between March 12, 2015, and March 31, 2025, and held or sold at a loss after April 1, 2025, are eligible to claim damages [3][6]. - Required documentation for claims includes stock transaction statements and a copy of the investor's ID, with legal fees typically structured as a contingency fee [6].

Core Viewpoint - Investors have won a first-instance victory in a lawsuit against Luopute Securities for false statements, indicating that similar cases will likely receive quicker judgments in the future [1][4]. Group 1: Legal Proceedings - The Shanghai Huzhi Law Firm has submitted a batch of cases to the court and is currently gathering affected investors [1][4]. - The lawsuit stems from a penalty received by the company in October 2023, where it was found to have falsified annual reports, violating the Securities Law and harming investor interests [1][4]. - Investors who purchased shares between April 20, 2021, and May 17, 2023, and sold or still hold shares after May 18, 2023, can join the lawsuit for compensation [1][4]. Group 2: Compensation Claims - The administrative penalty decision revealed that the company had signed three supply agreements with a total contract value of 242 million yuan in December 2020 [2][4]. - In 2021, the company and its wholly-owned subsidiary signed three supply agreements for six projects in Jiangsu Province and one project in Guizhou Province, with a total contract value of 149 million yuan [2][4]. - The company recognized revenue based on the delivery and acceptance by customers, but the control of the goods had not transferred to the customers at the time of revenue recognition, leading to false financial statements [5]. Group 3: Auditor Accountability - The case also implicates the auditing firm, Shanggong, which failed to perform due diligence during the audits of Luopute's financial statements for 2021 and 2022, resulting in false records [2][5]. - If Shanggong cannot prove its lack of fault, it may be held jointly liable for compensation alongside Luopute, providing investors with additional avenues for recovery [5].

Core Viewpoint - The China Securities Regulatory Commission (CSRC) has initiated an investigation into Zhejiang Sunflower Health Technology Co., Ltd. for misleading statements in its restructuring proposal, which has raised market concerns regarding the actual production capacity and business model of the restructuring target [1][3]. Group 1: Investigation and Legal Actions - The Zhejiang Securities Regulatory Bureau has found that the restructuring proposal of Sunflower may contain misleading statements, leading to a formal investigation [1][4]. - Investors who suffered losses due to alleged false statements can seek compensation through legal channels, as per the Supreme People's Court's judicial interpretation regarding false statements [4][5]. - The investigation will ensure the maintenance of order in the mergers and acquisitions market [1]. Group 2: Compensation Eligibility - Investors who purchased Sunflower shares (stock code: 300311) between September 22, 2025, and December 25, 2025, and still held them at the close on December 25, 2025, are eligible to file for compensation [2][4]. - Compensation claims can include losses from investment differences, commissions, and stamp duty losses [4][5]. - Investors must provide specific documentation, including securities account information, stock reconciliation statements from September 1, 2025, to the present, and contact information to support their claims [5].

受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 2026年1月14日，北京盈科（杭州）律师事务所陈宇霞律师向北京金融法院递交了一批股民针对东方通 （300379）的证券虚假陈述责任纠纷案的起诉材料，要求东方通赔偿股民相关损失。 该批系列索赔案件是基于东方通的信披违规行为，经北京证监局调查查明，东方通通过虚构业务、提前 确认收入等方式虚增2019年至2022年年度收入、利润，同时，东方通2022年6月至11月多次披露的《向 特定对象发行A股股票之募集说明书》（以下简称《募集说明书》）申报稿或注册稿引用了其2019年至 2021年年度报告中营业收入、利润总额等虚假财务数据，致使其证券发行文件编造重大虚假。 此前，东方通因上述违法违规行为，已被深圳证券交易所决定终止股票上市交易，预计最后交易日 期为2026年1月21日。（东方通维权入口） 索赔相关 按照相关法律法规的规定，上市公司证券虚假陈述，给投资人造成的投资损失，应当负赔偿责任，上市 公司退市不 ...

关于公司的立案缘由，为公司涉嫌年报等信息披露文件财务数据存在虚假记载等违法行为。此事也造成 公司股价大幅下跌，待监管调查结论一出，该公司也将遭到严惩。 一、涉虚假记载被立案 刘鹏律师表示该上市公司将被投资者以证券虚假陈述为由起诉索赔，暂定于2025年7月11日（含当日） 之前买入，并在2025年7月12日之后卖出或仍持有而亏损的即符合索赔要求可报名维权。（元道通信维 权入口） 公司方面，在面临监管调查和投资者索赔的双重压力下，其经营状况和市场形象都受到了极大的冲击， 后续发展令人担忧。 登录新浪财经APP 搜索【信披】查看更多考评等级 自元道通信（维权）于7月11日公告称被立案调查之后，已有大批受损投资者参与维权。上海沪紫律师 事务所刘鹏律师团队已于近日提交上百位投资者的案件至法院立案。 在此需提醒投资者的是该公司财报存疑且被立案调查，如仍交易，即便后续虚假陈述被查实，也可能因 为投资决定与虚假陈述之间的交易因果关系不成立，而无法获得索赔。信息披露的准确性对于投资者决 策和市场公平性至关重要，上市公司的年报或财报对投资者决策意义重大。受损投资者可查看是否符合 上诉条件，决定是否参与维权。 （本文由上海沪紫律师 ...

Core Viewpoint - Yuan Cheng Environment Co., Ltd. has been penalized for securities fraud, leading to potential compensation claims from affected investors [1][2][4]. Group 1: Company Violations - The Zhejiang Securities Regulatory Bureau found that Yuan Cheng Environment's annual reports from 2020 to 2022 contained false records, including inflated project costs and revenues [2][5]. - The company failed to timely account for discrepancies in the Huaiyin project, further inflating its 2022 annual report revenues [2][5]. - In 2022, the company fabricated significant false content in its non-public stock issuance documents [2][5]. Group 2: Penalties and Legal Actions - The company has been ordered to correct its actions, received a warning, and fined approximately 37.45 million yuan [2][5]. - The actual controller, Zhu Changren, has been banned from the securities market for 10 years [2][5]. - Affected investors who purchased Yuan Cheng Environment stock between April 15, 2021, and January 30, 2024, and still hold it as of January 30, 2024, may file for compensation [2][4]. Group 3: Compensation Process - Investors seeking compensation must provide original securities account information, stock reconciliation statements from April 1, 2021, to December 31, 2024, and detailed contact information [2][4].

受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我 2026年1月10日，宁波市天普橡胶科技股份有限公司（简称天普股份（维权）、代码：605255）发布 《关于收到中国证券监督管理委员会立案告知书的公告》。因公司股票交易异常波动公告涉嫌重大遗漏 等，根据《中华人民共和国证券法》、《中华人民共和国行政处罚法》等法律法规，中国证监会决定对 公司进行立案。 曾代理投资者告赢130余家上市公司并获赔的浙江裕丰律师事务所厉健律师表示，根据立案公告，天普 股份涉嫌证券虚假陈述，受损投资者可依法索赔。 （厉健律师专栏） "司法解释已取消前置程序，根据立案公告等初步证据，投资者也可以起诉索赔。"厉健律师表示，根据 司法解释，暂定：在2025年12月30日收盘还持有普股份股票的受损股民，可依法索赔。索赔条件将根据 证监会调查结论进一步调整，最终以法院认定为准。（天普股份维权入口） 投资者索赔需提供证券开户信息查询单、股票对账单（首次买入该股票之日至今）、联系方式等。 曾 ...

Core Viewpoint - Guangdong Jushi Chemical Co., Ltd. (stock code: 688669) is facing administrative penalties for alleged securities fraud, specifically for false disclosures related to inflated revenues, costs, and profits through fictitious trade activities [1][4]. Summary by Relevant Sections Allegations and Findings - The Guangdong Securities Regulatory Bureau has identified that Jushi Chemical and its subsidiaries engaged in false trade activities to inflate financial figures. This includes controlling four trading companies to conduct non-existent trades and manipulating trade chains without commercial substance [4]. - The company reported inflated operating income of approximately 156.81 million yuan, inflated operating costs of about 158.47 million yuan, and a reduced profit of around 1.66 million yuan for the first half of 2023, representing 8.32%, 8.51%, and 6.81% of total revenue, costs, and profit respectively [4]. Penalties - The regulatory body plans to impose a fine of 2.4 million yuan on Jushi Chemical, along with warnings to the responsible personnel and additional fines [4]. Investor Compensation - Investors affected by the alleged fraud can file for compensation under the Supreme People's Court's judicial interpretation regarding false statements. This includes claims for losses incurred from the stock's price difference, commissions, and stamp duty [5]. - Investors who purchased Jushi Chemical shares between August 29, 2023, and November 21, 2025, and still hold them as of the latter date are eligible to seek compensation, subject to court validation [5].

回顾本案，2024年8月5日，公司及公司控股股东上海鹏欣（集团）有限公司（以下简称"鹏欣集团"）于 近日收到中国证券监督管理委员会（以下简称"中国证监会"）下发的《立案告知书》（编号：证监立案 字0132024004、证监立案字0132024005号），公司及公司控股股东鹏欣集团因涉嫌信息披露违法违规， 根据《中华人民共和国证券法》《中华人民共和国行政处罚法》等法律法规，中国证监会决定对公司及 公司控股股东鹏欣集团进行立案。2024年11月20日，公司及相关责任人收到中国证券监督管理委员会湖 南监管局下发的《行政处罚决定书》，经查明，当事人存在以下违法事实：一、鹏都农牧未依法及时披 露控股股东非经营性资金占用；二、鹏都农牧2020年年度报告、2021年半年度报告、2021年年度报告、 2022年半年度报告、2022年年度报告存在重大遗漏； 信本股民索赔团队提醒，鹏都农牧案件一审即将开庭，因此受损的投资者，可通过"新浪股民维权平 台"自愿登记索赔。 维权条件： 鹏都农牧：根据相关司法解释，符合以下条件的投资者可发起索赔：于2021年4月29日-2024年8月14日 期间买入且有持仓，无论在2024年8月15日及 ...